Why the study?
Patients with concomitant heart failure, type 2 diabetes, and chronic kidney disease often receive fragmented counselling across specialty pathways, which may limit uptake and persistence of integrated cardio-renal-metabolic care.
Does a structured cardio–renal–metabolic integrated education pathway reduce time to first heart failure hospitalisation or all-cause death compared with usual education in adults with chronic heart failure, type 2 diabetes, and chronic kidney disease stage 2–4?
Does a structured cardio–renal–metabolic integrated education pathway reduce time to first heart failure hospitalisation or all-cause death compared with usual education in adults with chronic heart failure, type 2 diabetes, and chronic kidney disease stage 2–4?
In outpatients with overlapping heart failure, type 2 diabetes, and chronic kidney disease, an integrated cardio–renal–metabolic education pathway was associated with lower rates of heart failure hospitalisation or death, improved quality of life, better glycaemic control, and slower kidney function decline.
Answers are grounded in this paper and cite their sources.
May support integrated education in multimorbid outpatients; leaves open need for randomized confirmation.
Background Patients living with concomitant heart failure, type 2 diabetes and chronic kidney disease often receive fragmented counselling across specialty pathways, potentially limiting uptake and persistence of integrated cardio–renal–metabolic care. Purpose To evaluate whether a structured cardio–renal–metabolic integrated education pathway improves clinical and patient-centred outcomes compared with usual education in routine outpatient practice. Methods In a pragmatic, prospective controlled cohort study, adults with chronic heart failure, type 2 diabetes and chronic kidney disease stage 2–4 were enrolled and allocated by alternate-week clinic scheduling to cardio–renal–metabolic integrated education or usual education (450 vs 450). Follow-up was 12 months. The primary endpoint was time to first heart failure hospitalisation or all-cause death. Secondary outcomes included change in Kansas City Cardiomyopathy Questionnaire-12 score, glycated haemoglobin, estimated glomerular filtration rate slope, and safety events. Associations were estimated using adjusted time-to-event and longitudinal models. Results Twelve-month follow-up was completed in 862/900 (95.8%). Primary events occurred in 78/450 (17.3%) with integrated education versus 111/450 (24.7%) with usual education (adjusted hazard ratio 0.68, 95% confidence interval 0.51–0.90; p=0.006). Heart failure hospitalisation was reduced (63/450 [14.0%] vs 92/450 [20.4%]) with a smaller difference in all-cause death (20/450 [4.4%] vs 29/450 [6.4%]). Health status improved more with integrated education at 6 months (Kansas City Cardiomyopathy Questionnaire-12 change +11.1 vs +5.2; between-group difference +5.8 points, 95% confidence interval +3.9 to +7.6; p<0.001). Glycaemic control improved (glycated haemoglobin change −0.71% vs −0.19%; adjusted difference −0.52%, 95% confidence interval −0.70 to −0.34; p<0.001). Kidney function decline was slower (estimated glomerular filtration rate slope difference +1.6 mL/min/1.73 m²/year, 95% confidence interval +0.8 to +2.4; p<0.001). Genital mycotic infection was more frequent (12/450 [2.7%] vs 6/450 [1.3%]). Conclusion In routine outpatient care, a pragmatic cardio–renal–metabolic integrated education pathway was associated with fewer heart failure hospitalisations and improved patient-reported health status and cardio–renal–metabolic measures, with a small increase in genital mycotic infection. These data support systematic, cross-condition education as a scalable component of integrated care for this high-risk overlap population.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: